[Business Wire] – GE Healthcare today announced results from a new study, which showed that patients receiving Visipaque™ were less likely to experience discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving Isovue® .
Read more on this.
General … [visit site to read more]
Similar posts:- Stock Update: United Parcel Service Inc. (NYSE:UPS) – Elon Musk says Tesla may build electric pickup truck modeled after Ford F-150
- Company Update: Morgan Stanley (NYSE:MS) – Moelis taps Morgan Stanley healthcare banker
- Bayer names Pfizer’s Brandicourt as head of healthcare – Pfizer (PFE)